STUDY ON RELATIONSHIP BETWEEN CHEMOSENSITIVITY OFBREAST CANCER AND EXPRESSION OF p73α AND p53

被引:0
|
作者
周鑫
孙治君
机构
[1] Chongqing University of Medical Sciences
[2] Chongqing University of Medical Sciences Chongqing 400016
[3] The First Affiliated Hospital
[4] Department of General Surgery
关键词
Breast cancer; p73α; p53; Chemosensitivity;
D O I
暂无
中图分类号
R737.9 [乳腺肿瘤];
学科分类号
100214 ;
摘要
Objective: To investigate the relationship between the expression of p73α and p53 versus the chemosensitivity in breast cancer cells. Methods: Twelve surgical samples of breast cancer diagnosed by pathology were used. The cancer sample cells were separately cultured in the incubator at 37°C, 5% CO2 in vitro. The relative inhibition rate of cancer cells by 4 kinds of anticancer drugs, which were EPI, MMC, 5-Fu and DDP, were assayed by MTT method. Immunocytochemistry was used to detect the expression of p73α and p53 in the cancer cells. Results: The positive expression of p73α was found in 5/12 (41.67%), and p53 positive expression rate was 50.0% (6/12). The relative inhibition rate of MMC, EPI, 5-Fu and DDP were significantly higher in the p73α positive cancer cells than in the p73α negative cancer cells. A positive correlation was found between expression of p73α and chemosensitivity for all the four anticancer drugs. Conclusion: The expression of p73α is related with the chemosensitivity of the breast cancer cells, and it may become one of the markers for judging the effect of chemotherapy in clinic.
引用
收藏
页码:224 / 226
页数:3
相关论文
共 50 条
  • [31] Comparative analysis of p73 and p53 regulation and effector functions
    Fang, L
    Lee, SW
    Aaronson, SA
    JOURNAL OF CELL BIOLOGY, 1999, 147 (04) : 823 - 830
  • [32] The p53/p63/p73 family of proteins - the focus on isoforms and mutants in cancer
    Slade, Neda
    Zoric, Arijana
    Horvat, Andela
    PERIODICUM BIOLOGORUM, 2010, 112 (04) : 425 - 432
  • [33] Targeting of p53 and its homolog p73 by protoporphyrin IX
    Sznarkowska, Alicja
    Malenczyk, Katarzyna
    Kadzinski, Leszek
    Bielawski, Krzysztof P.
    Banecki, Bogdan
    Zawacka-Pankau, Joanna
    FEBS LETTERS, 2011, 585 (01) : 255 - 260
  • [34] A ribonucleotide reductase gene is a transcriptional target of p53 and p73
    Nakano, K
    Bálint, É
    Ashcroft, M
    Vousden, KH
    ONCOGENE, 2000, 19 (37) : 4283 - 4289
  • [35] Regulation of telomerase activity by the p53 family member p73
    Beitzinger, M
    Oswald, C
    Beinoraviciute-Kellner, R
    Stiewe, T
    ONCOGENE, 2006, 25 (06) : 813 - 826
  • [36] A ribonucleotide reductase gene is a transcriptional target of p53 and p73
    Katsunori Nakano
    Éva Bálint
    Margaret Ashcroft
    Karen H Vousden
    Oncogene, 2000, 19 : 4283 - 4289
  • [37] Differential modulation of cellular and viral promoters by p73 and p53
    Deb, D
    Lányi, A
    Scian, M
    Keiger, J
    Brown, DR
    Le Roith, D
    Deb, SP
    Deb, S
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2001, 18 (02) : 401 - 409
  • [38] P53 mutations and resistance to chemotherapy: a stab in the back for p73?
    Soussi, T
    BULLETIN DU CANCER, 2003, 90 (05) : 383 - 386
  • [39] Analysis of p73 and p53 gene deletions in multiple myeloma
    B Schultheis
    A Krämer
    A Willer
    U Hegenbart
    H Goldschmidt
    R Hehlmann
    Leukemia, 1999, 13 : 2099 - 2103
  • [40] Regulation of telomerase activity by the p53 family member p73
    M Beitzinger
    C Oswald
    R Beinoraviciute-Kellner
    T Stiewe
    Oncogene, 2006, 25 : 813 - 826